The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

ABSTRACTIndices for predicting HBsAg or HBeAg seroconversion in patients with chronic hepatitis B virus (HBV) infection during antiviral therapy remain elusive. We aimed to investigate if the presence of HBsAb-specific B cells at baseline can predict HBsAg or HBeAg seroconversion. In this study, 134...

Full description

Bibliographic Details
Main Authors: Shengxia Yin, Yawen Wan, Rahma Issa, Yijia Zhu, Xiaoming Xu, Jiacheng Liu, Minxin Mao, Ming Li, Xin Tong, Chen Tian, Jian Wang, Rui Huang, Qun Zhang, Chao Wu, Yuxin Chen, Jie Li
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
HBsAb
Chronic HBV
HBsAg seroconversion
Peg-IFN-α treatment
ELIspot
HBsAb-specific B cells
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2259003

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2023.2259003

Similar Items